Group One Trading
BNTX icon

Group One Trading’s BioNTech BNTX Stock Holding History

Group One Trading’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27M Buy
35,100
+13,900
+66% +$1.31M ﹤0.01% 1765
2026
Q1 		$1.88M Sell
21,200
-36,400
-63% -$3.74M ﹤0.01% 2121
2025
Q4 		$5.48M Buy
57,600
+39,200
+213% +$3.95M 0.01% 1409
2025
Q3 		$1.81M Sell
18,400
-39,200
-68% -$4.19M ﹤0.01% 2416
2025
Q2 		$6.13M Sell
57,600
-3,900
-6% -$394K 0.01% 1161
2025
Q1 		$5.6M Sell
61,500
-75,600
-55% -$8.46M 0.02% 987
2024
Q4 		$15.6M Sell
137,100
-122,500
-47% -$14M 0.04% 479
2024
Q3 		$30.8M Buy
259,600
+137,100
+112% +$12.6M 0.09% 173
2024
Q2 		$9.84M Buy
122,500
+71,100
+138% +$6.5M 0.04% 457
2024
Q1 		$4.74M Sell
51,400
-136,700
-73% -$13.1M 0.02% 860
2023
Q4 		$19.9M Buy
188,100
+122,400
+186% +$12.3M 0.05% 351
2023
Q3 		$7.14M Sell
65,700
-21,300
-24% -$2.36M 0.02% 709
2023
Q2 		$9.39M Buy
87,000
+37,300
+75% +$4.2M 0.03% 545
2023
Q1 		$6.19M Sell
49,700
-118,500
-70% -$16.3M 0.02% 728
2022
Q4 		$25.3M Buy
168,200
+44,700
+36% +$6.88M 0.06% 323
2022
Q3 		$16.7M Buy
123,500
+900
+0.7% +$138K 0.03% 475
2022
Q2 		$18.3M Sell
122,600
-15,300
-11% -$2.34M 0.03% 521
2022
Q1 		$23.5M Sell
137,900
-108,500
-44% -$18.2M 0.02% 531
2021
Q4 		$63.5M Buy
246,400
+23,600
+11% +$6.46M 0.05% 249
2021
Q3 		$60.8M Buy
222,800
+116,200
+109% +$36.9M 0.07% 232
2021
Q2 		$23.9M Buy
106,600
+30,300
+40% +$5.71M 0.03% 537
2021
Q1 		$8.33M Sell
76,300
-35,100
-32% -$3.73M 0.01% 1078
2020
Q4 		$9.08M Sell
111,400
-87,100
-44% -$8.55M 0.02% 865
2020
Q3 		$13.7M Buy
198,500
+169,900
+594% +$12.2M 0.04% 397
2020
Q2 		$1.91M Buy
+28,600
New +$1.43M 0.01% 1498

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Group One Trading's BNTX Position: Q2 2026 in Review

Group One Trading reduced its BioNTech (BNTX) stake by 79% in Q2 2026, selling an estimated $7.76M and leaving 21,540 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2215.

Group One Trading first reported a position in BNTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $38.1M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Group One Trading held 21,540 shares of BioNTech worth $2M as of Q2 2026.
  • Group One Trading sold 82,408 BioNTech shares in Q2 2026, an estimated $7.76M.
  • BioNTech made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #2215 holding.
  • Group One Trading first reported a position in BioNTech in Q2 2020 and has held it in 25 quarters since.
  • Group One Trading's BioNTech position peaked at $38.1M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.